Søgeresultater - Maximiliano Van Kooten

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer

    A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer af José Rodrigues-Pereira, Joo-Hang Kim, Manuel Magallanes, Dae Ho Lee, Jie Wang, Vinod Ganju, Luis Manuel Martínez-Barrera, Helen Barraclough, Maximiliano Van Kooten, Mauro Orlando

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

    Erlotinib in Previously Treated Non–Small-Cell Lung Cancer af Frances A. Shepherd, José Rodrigues Pereira, Tudor‐Eliade Ciuleanu, Eng Huat Tan, Vera Hirsh, Sumitra Thongprasert, Daniel de Castro, Savitree Maoleekoonpiroj, Michael Smylie, Renato Martins, Maximiliano Van Kooten, Mircea Dediu, B. Findlay, Dongsheng Tu, D. Johnston, Andrea Bezjak, Gary M. Clark, P. Santabárbara, Lesley Seymour

    Udgivet 2005
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    LBA8 Phase III study of cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC) of IMDC intermediate or poor risk (COSMIC-313)

    LBA8 Phase III study of cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC) of IMDC intermediate or p... af Toni K. Choueiri, Tom Powles, Laurence Albigès, M. Burotto, C. Szczylik, B. Zurawski, E. Yanez Riuz, Marco Maruzzo, Alberto Suárez Zaizar, Luis Fein, Fabio A. Schutz, Daniel Yick Chin Heng, F. Wang, Fabio Mataveli, Yih‐Leong Chang, Maximiliano van Kooten Losio, C. Suárez Rodríguez, Robert J. Motzer

    Udgivet 2022
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

    Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma af Toni K. Choueiri, Thomas Powles, Laurence Albigès, Mauricio Burotto, Cezary Szczylik, Bogdan Żurawski, Eduardo Yañez Ruiz, Marco Maruzzo, Alberto Suárez Zaizar, Luis Fein, Fabio A. Schutz, Daniel Y.C. Heng, Fong Wang, Fabio Mataveli, Yu-Lin Chang, Maximiliano van Kooten Losio, Cristina Suárez, Robert J. Motzer

    Udgivet 2023
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: